Brainstorm Cell Therapeutics Inc. Stock Forecast
Volatile ride for Brainstorm Cell Therapeutics Inc. stock price on Wednesday moving between $0.330 and $0.366
(Updated on Jul 03, 2024)
The Brainstorm Cell Therapeutics Inc. stock price fell by -3.00% on the last day (Wednesday, 3rd Jul 2024) from $0.353 to $0.342. During the last trading day the stock fluctuated 10.78% from a day low at $0.330 to a day high of $0.366. The price has fallen in 7 of the last 10 days and is down by -14.42% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -195 thousand shares and in total, 129 thousand shares were bought and sold for approximately $44.08 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.95% during the next 3 months and, with a 90% probability hold a price between $0.167 and $0.370 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
BCLI Signals & Forecast
There are mixed signals in the stock today. The Brainstorm Cell Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.362 and $0.454. A break-up above any of these levels will issue buy signals. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Friday, June 28, 2024, and so far it has risen 1.15%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Brainstorm Cell Therapeutics Inc. stock
Brainstorm Cell Therapeutics Inc. finds support from accumulated volume at $0.339 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0356 between high and low, or 10.78%. For the last week the stock has had daily average volatility of 11.35%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (BCLI) For The Upcoming Trading Day Of Friday 5th
For the upcoming trading day on Friday, 5th we expect Brainstorm Cell Therapeutics Inc. to open at $0.346, and during the day (based on 14 day Average True Range), to move between $0.290 and $0.395, which gives a possible trading interval of +/-$0.0524 (+/-15.30%) up or down from last closing price. If Brainstorm Cell Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 30.59% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.339 (1.14%) than the resistance at $0.360 (5.26%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Brainstorm Cell Therapeutics Inc. stock A Buy?
Brainstorm Cell Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -4.689 Sell Candidate Unchanged
Predicted Opening Price for Brainstorm Cell Therapeutics Inc. of Friday, July 5, 2024
| Fair opening price July 5, 2024 | Current price |
|---|---|
| $0.346 ( 1.11%) | $0.342 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for BCLI
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.382 | 11.51% |
| R2 | 0.368 | 7.54% |
| R1 | 0.360 | 5.08% |
| Price | 0.342 | |
| S1 | 0.333 | -2.86% |
| S2 | 0.324 | -5.32% |
| S3 | 0.311 | -9.29% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.378 | 10.25% |
| R2 | 0.374 | 9.23% |
| R1 | 0.360 | 5.26% |
| Price | 0.342 | |
| S1 | 0.339 | -1.14% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Brainstorm Cell Therapeutics Inc. Stock.
